Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior IP Counsel, Life Sciences Attorney

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Oct 7, 2020

View more

Discipline
Regulatory, Legal/Compliance
Required Education
Doctorate/PHD/MD
Position Type
Full time
Hotbed
Genetown

Job Details

Our mission:

Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

At Intellia, we are committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to create novel engineered cell therapies for immuno-oncological and autoimmune diseases.

Summary:

Intellia seeks an experienced biotechnology or chemistry patent attorney to join our legal group in Cambridge, Massachusetts. The attorney will develop and execute a global intellectual property strategy in support of Intellia's gene editing technology and product programs. We are looking for someone who can develop and implement solutions, appropriately analyze and manage risks, multitask, and communicate well. Most importantly, we seek a team member who wants to be fully integrated into every aspect of the company from research to business execution.

Responsibilities:
    • Help lead the development of a worldwide IP portfolio covering new IP to therapeutic applications of CRISPR-Cas9.
    • Identify patentable inventions through regular interactions with internal R&D project teams, and work with outside counsel to draft, file, and prosecute patent applications worldwide.
    • Provide legal advice to internal science, business, and legal teams on a variety of IP related matters.
    • Conduct due diligence assessments and counsel based on those assessments, including freedom-to-operate (FTO), infringement and validity analyses, and risk evaluation and mitigation.
    • Work on transactions and legal matters supporting Intellia's research and business goals, such as licensing, collaborations, and other contracts (e.g., consulting, research, service, vendors, manufacturing).
    • Analyze trademark and copyright issues.
    • Assist with challenging and defending patents in PTAB, opposition proceedings, and other forums.
    • Interface with key stakeholders, including collaborators, government agencies, consultants, and other third parties.
    • Work on other assigned legal matters relevant to the Company.


Qualifications:
    • J.D. degree or LL.M. degree from an accredited law school, admission to practice law in a U.S. jurisdiction, and at least four years' experience as a patent agent or patent attorney registered to practice before the U.S. Patent and Trademark Office.
    • Significant prior legal experience in the pharmaceutical and/or biotechnology fields, with an emphasis on preparation, prosecution, and IP analysis a must.
    • Strong preference for advanced scientific degree (Ph.D. or Master's) in molecular biology, cell biology, biochemistry, chemistry, immunology, genetics, structural biology, or related field.
    • The successful candidate will be capable of managing multiple projects simultaneously in a fast-paced environment, and will possess excellent analytic, legal drafting, and oral and written communication skills.
    • Six or more years of experience practicing patent or intellectual property law.
    • Experience in all aspects of U.S. and foreign intellectual property law relating to biotechnology, pharmaceutical, or life sciences at a law firm or a biotechnology/pharmaceutical corporation.
    • In addition to the basic qualifications listed above, the ideal candidate will have demonstrated leadership, management, and interpersonal skills, and creativity in applying analytical frameworks and solutions to issues.
    • Strong client service focus and ability to work independently and in teams, as well as excellent organizational skills, flexibility, and ability to prioritize workflows.


#LI-DG1

What Intellia Stands For:

We push boundaries. We are focused on positively disrupting health care treatment of patients with genomic diseases. The values we live by and drivers we look for are:

- One is respect for individuals; our unique qualities and strengths; our own ways to understand, learn and improve. One is our single-minded determination to excel; to succeed together. One is you and us - trusting and counting on every single one of us.

- Explore because we seek new ways to tackle disease. Explore with unbounded minds...free from assumptions, open to ideas. Explore by staying curious, by pushing boundaries, overcoming obstacles. Explore means thinking of new ways.

- Disrupt by thinking courageously...and creating a better future. Disrupt by defying conformity; interrogating the status quo; questioning our momentum. Disrupt with challenging thoughts...with that breed of skepticism that shows you have better solutions.

- Deliver with your focus on the objective and your determination to complete the task. Deliver by advancing relentlessly and by maintaining high standards...even when nobody is watching. Deliver by staying accountable and pulling your weight. Deliver because patients are counting on us to make the promise reality. Get it done.

POSITION: Full-Time, Exempt

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Intellia's web-based application process is managed through Lever. Information submitted through application forms is collected by Lever and subject to Lever's privacy policy .

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert